Open AccessInfection With the USNeisseria meningitidisUrethritis Clade Does Not Lower Future Risk of Urethral Gonorrhea
Author(s) -
Abigail Norris Turner,
Alex M. Carter,
Yih-Ling Tzeng,
David S. Stephens,
Morgan Brown,
Brandon Snyder,
Adam C. Retchless,
Xin Wang,
José A. Bazan
Publication year - 2021
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab824
Subject(s) - gonorrhea , medicine , urethritis , neisseria gonorrhoeae , neisseria meningitidis , urethra , hazard ratio , neisseriaceae , neisseria , cohort , chlamydia , gynecology , urology , microbiology and biotechnology , immunology , confidence interval , antibiotics , biology , bacteria , genetics , human immunodeficiency virus (hiv)
Cross-protective immunity between Neisseria meningitidis (Nm) and Neisseria gonorrhoeae (Ng) may inform gonococcal vaccine development. Meningococcal serogroup B (MenB) outer membrane vesicle (OMV) vaccines confer modest protection against gonorrhea. However, whether urethral Nm infection protects against gonorrhea is unknown. We examined gonorrhea risk among men with US Nm urethritis clade (US_NmUC) infections.